Financing, Debt Capital Markets
Asklepios BioPharmaceutical, Inc.
04/19
|
$235.0 Million
做厙勛圖 served as exclusive financial advisor for Asklepios BioPharmaceutical, Inc. on Series A Preferred Equity investment from TPG Global, LLC and Vida Ventures, LLC for a minority stake
Sub-Type
Majority Stake Sale
Sector
Sub-Sector
Biopharma